Results 31 to 40 of about 65,141 (315)

Regulatory, scientific, and ethical issues arising from institutional activity in one of the 90 Italian Research Ethics Committees

BMC Medical Ethics, 2021
Background This paper highlights the issues that one of the 90 Italian Research Ethics Committees (RECs) might encounter during the approval phase of a clinical trial to identify corrective and preventive actions for promoting a more efficient review ...
G. Benfatto, Regulatory Group, Ethics Committee Catania 1 (Group), F. Drago   +3 more
doaj   +1 more source

An evaluation of postmarketing reports of hyperglycaemia associated with dolutegravir for treatment of HIV in Eswatini

AIDS Research and Therapy, 2022
Background Dolutegravir (DTG) is an Integrase Strand Transfer Inhibitor (INSTI) indicated in combination with other antiretroviral agents for the treatment of HIV infection.
Alemayehu L. Duga, Sibongile Magongo, Siphesihle Nhlabatsi, Denis O. Ladwar, Linda Härmark, Leàn Rolfes   +5 more
doaj   +1 more source

Pharmacovigilance in vaccines

Indian Journal of Pharmacology, 2010
Sir, Vaccines are among the safest tools of modern medicine that help in protecting against disease by inducing immunity. In all countries, routine immunization represents a fundamental service of the public health system, offering one of the most cost-effective methods of reducing morbidity and mortality among children less than five.
Budhiraja, Salil, Akinapelli, Raghuram
openaire   +4 more sources

Need for the Development of Dialectical Thinking in Pharmaceutical Personnel to Improve Their Performance in the Pharmacovigilance System

Безопасность и риск фармакотерапии, 2022
The pharmacovigilance system aimed at ensuring the safety of medicines has been functioning in Russia since 1997. However, at the moment, an important part of this system, pharmacy organisations, is not sufficiently involved in pharmacovigilance ...
A. E. Krasheninnikov, B. K. Romanov, R. S. Safiullin, N. V. Shestakov   +3 more
doaj   +1 more source

Medication errors safety signals COVID-19-related Moroccan Pv database [PDF]

E3S Web of Conferences, 2021
On March 23, 2020, the Moroccan Ministry of Health issued a circular authorizing the off label use of hydroxychloroquine or chloroquine in combination with azythromycin as first-line treatment for all COVID-19 patients. The aim of this study is to detect,
Sefiani Houda, Benabdallah Ghita, Tebaa Amina, Soulaymani Bencheikh Rachida   +3 more
doaj   +1 more source

Assessing the 2004-2018 fentanyl misusing issues reported to an international range of adverse reporting systems [PDF]

, 2019
© 2019 Schifano, Chiappini, Corkery and Guirguis. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY).
Chiappini, Stephania, Corkery, John, Guirguis, Amira, Schifano, Fabrizio   +3 more
core   +4 more sources

Vaccination process evaluation at COVID-19 vaccination centers in Lebanon: a national study

Journal of Pharmaceutical Policy and Practice, 2022
Background Upon the authorization of COVID-19 vaccines worldwide, national and international standards were developed to help integrate mass COVID-19 immunization campaigns into the healthcare network.
Abeer Zeitoun, Souheil Hallit, Maya Helali, Sirine Chehade, Carla Allam, Aya Ibrahim, Hani Dimassi, Rita Karam   +7 more
doaj   +1 more source

The risk of preterm labor after COVID-19 vaccination before and during pregnancy

Frontiers in Drug Safety and Regulation, 2023
Background: Pregnant women have a higher risk of severe illness and adverse pregnancy outcomes due to a SARS-CoV-2 infection. COVID-19 vaccination can prevent (severe) infection.
M. de Feijter, L. C. M. Vissers, L. Davidson, A. C. Kant, A. C. Kant, P. J. Woestenberg   +5 more
doaj   +1 more source

Kounis Syndrome Associated With Selective Anaphylaxis to Cefazolin. [PDF]

, 2018
info:eu-repo/semantics ...
Chambel, M, Correia, M, Gaspar, A, Morais-Almeida, M, Mota, I, Sequeira, T   +5 more
core   +1 more source

Pharmacovigilance workflow in Europe and Italy and pharmacovigilance terminology [PDF]

International Journal of Clinical Pharmacy, 2018
AbstractThe terminology used in pharmacovigilance can cause confusion, because there are similar terms that describe different phenomena (e.g. adverse reactions, adverse drug reactions, and side effects). Incorrect use of terminology can have negative effects on the reporting of adverse drug reactions and on the interpretation of these reports.
Paolo Baldo, Sara Francescon, Giulia Fornasier   +2 more
openaire   +3 more sources